Calibrate and Found are most likely to require synchronous consultations

#GLP1 #Pharma #Strategy #MarketAccess #PharmaGambit To view or add a comment, sign in AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS VESALIUS-CV Subgroup Results Show Repatha Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in Current Obesity and Diabetes Care THOUSAND OAKS, Calif., [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News To view or add a comment, sign in AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS VESALIUS-CV Subgroup Results Show Repatha Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in Current Obesity and Diabetes Care THOUSAND OAKS, Calif., [...] To view or add a comment, sign in Imagine telling a pharmacist in 2015: A diabetes drug will soon be used for weight loss, heart protection, kidney disease, fatty liver disease, and even sleep apnea. Most people would have laughed

Impact on Medspas Many medspas have turned to compounded tirzepatide to meet the surging demand for weight loss treatments
The clinic holds a 3.8/5 rating on Trustpilot across nearly 2,000 reviews, with most patients highlighting the straightforward process and helpful coaching access